Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
IFN-λ cancer immunotherapy: New kid on the block
Ahmed Lasfar
, Helen Gogas
, Andrew Zloza
, Howard L. Kaufman
, John M. Kirkwood
Research output
:
Contribution to journal
›
Review article
›
peer-review
37
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'IFN-λ cancer immunotherapy: New kid on the block'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Cancer Immunotherapy
100%
Interferon lambda (IFN-λ)
100%
Oncology
20%
Clinical Trials
10%
Innate Immune Response
10%
Adaptive Immune Response
10%
Tumor Cells
10%
Therapeutic Benefits
10%
Selective Targeting
10%
Novel Agents
10%
Biologic Characteristics
10%
Cell-selective
10%
Murine Tumor Model
10%
Immunotherapy Agents
10%
Immune Checkpoint Inhibitors
10%
Off-target Binding
10%
Medicine and Dentistry
Interferon
100%
Cancer Immunotherapy
100%
Oncology
20%
Clinical Trial
10%
Innate Immunity
10%
Adaptive Immunity
10%
Tumor Cell
10%
Immunotherapy
10%
Cancer Model
10%
Immune Checkpoint Inhibitor
10%
Side Effect
10%